Skip to main content
Premium Trial:

Request an Annual Quote

A New Ticker

The Mountain View, Calif.-based sequencing-as-a-service company Complete Genomics "plans to sell up to an estimated $86.3 million in an initial public offering," according to the Wall Street Journal, and is "staking its claim to the ticker symbol GNOM" on the Nasdaq, the San Jose Mercury News reports. See GenomeWeb Daily News coverage of the company's IPO, including details from its SEC filing, here.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.